In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
Crossref DOI link: https://doi.org/10.1007/s00213-014-3680-5
Published Online: 2014-07-26
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, Prabhat
Sharma, Bhupesh
Gupta, Surbhi
Sharma, B. M.
Text and Data Mining valid from 2014-07-26